معرفی
Bernard Chatelain is a prominent researcher affiliated with the Namur Thrombosis and Hemostasis Center and the Catholic University of Louvain (UCLouvain), specializing in thrombosis, hemostasis, and anticoagulant therapies. His work bridges clinical laboratory practices with research on fibrinolytic systems, microparticles in thrombotic diseases, and thrombotic risk management during pandemics like COVID-19.
- Recent Research Focus: Development of integrative assays for fibrinolytic system phenotyping, optimization of coagulation testing protocols, and analysis of anticoagulant impacts on platelet function.
- Collaborations: Active partnerships with institutions like UCLouvain, Université de Namur, and international hemostasis laboratories.
His scientific contributions include over 146 research outputs, with recent publications addressing:
- Standardization of prothrombin time measurements using novel thromboplastin reagents.
- Time-sensitive variables in platelet testing accuracy.
- Thrombotic risk mitigation frameworks during global health crises.
Chatelain’s work has informed clinical guidelines and been referenced in policy documents, highlighting its translational significance.
۰مقاله منتشرشده
